Paul Tempst
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Paul Tempst as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT00773773 · Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With CancerMemorial Sloan Kettering Cancer Center · terminated · Prostate Cancer, Elevated Prostate Specific Antigen (PSA) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Protein and proteolytic activity biomarkers of early stage pancreatic cancerR01CA208401 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2017 to 2021 · $623,472 awarded in 2021Same name and institution; not confirmed by an ID
- Immobilized protease activity tests for developing functional cancer biomarkers.R21CA174537 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2014 to 2016 · $229,550 awarded in 2016Same name and institution; not confirmed by an ID
- MICROCHEMISTRY and PROTEOMICSP30CA008748 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 1996 to 2011 · $54,577 awarded in 2011Same name and institution; not confirmed by an ID
- Assessment of serum peptide profiling to detect cancer-specific patternsU24CA126485 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2006 to 2010 · $1,418,018 awarded in 2010Same name and institution; not confirmed by an ID
- Peptide Profiling Techniques to Detect Thyroid CarcinomaR33CA111942 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2006 to 2007 · $307,752 awarded in 2007Same name and institution; not confirmed by an ID
- Peptide Profiling Techniques to Detect Thyroid CarcinomaR21CA111942 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2005 · $143,964 awarded in 2005Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.